๐๏ธ OncologyInjection (IV)
Yescarta
Axicabtagene Ciloleucel
CD19-directed CAR T-cell therapy for relapsed/refractory large B-cell lymphoma and follicular lymphoma.
Form
Injection (IV)
Uses
3
Side effects
5
Category
Oncology
01
What is Yescarta used for?
- Relapsed/refractory large B-cell lymphoma
- Follicular lymphoma
- Primary mediastinal B-cell lymphoma
02
Axicabtagene Ciloleucel side effects
The following side effects have been reported for Axicabtagene Ciloleucel. Their order does not indicate how often an effect occurs.
Cytokine release syndrome
Neurotoxicity (ICANS)
Infections
Cytopenias
Hypogammaglobulinemia
03
Axicabtagene Ciloleucel warnings & precautions
- Black box: CRS and neurological toxicities
- REMS required
- Secondary T-cell malignancies reported
Loading FDA dataโฆ
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Yescarta in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.